Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18800910 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | August 2024 | December 2024 | Allow | 4 | 1 | 0 | No | No |
| 18764943 | N-TERMINAL MODIFIER AGENTS AND BINDERS FOR TREATING AND ANALYZING PEPTIDES | July 2024 | July 2025 | Allow | 12 | 2 | 1 | Yes | No |
| 18764600 | EFFICIENTLY CHARACTERIZING PROTEIN-PROTEIN INTERACTIONS | July 2024 | October 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18660053 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | June 2025 | Allow | 14 | 0 | 0 | No | No |
| 18659334 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | March 2025 | Allow | 10 | 0 | 0 | No | No |
| 18610717 | METHODS AND COMPOSITIONS USING ONE-SIDED TRANSPOSITION | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18590738 | ARRAYS INCLUDING A RESIN FILM AND A PATTERNED POLYMER LAYER | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18433344 | METHOD FOR PREDICTING THE OFF-TARGET BINDING OF A PEPTIDE WHICH BINDS TO A TARGET PEPTIDE PRESENTED BY A MAJOR HISTOCOMPATIBILITY COMPLEX | February 2024 | March 2026 | Abandon | 25 | 2 | 0 | No | No |
| 18409174 | METHODS, COMPOSITIONS, AND SYSTEMS FOR SPATIAL ANALYSIS OF ANALYTES IN A BIOLOGICAL SAMPLE | January 2024 | May 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18402273 | METHODS OF SELECTING BINDING REAGENTS | January 2024 | January 2026 | Allow | 25 | 4 | 0 | Yes | No |
| 18388735 | PROCESSES AND SYSTEMS FOR PREPARATION OF NUCLEIC ACID SEQUENCING LIBRARIES AND LIBRARIES PREPARED USING SAME | November 2023 | October 2025 | Allow | 23 | 2 | 0 | Yes | No |
| 18492069 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | October 2023 | November 2024 | Allow | 13 | 1 | 2 | Yes | No |
| 18484871 | HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION SCREENING IN YEAST LIQUID CULTURE | October 2023 | November 2025 | Abandon | 26 | 2 | 0 | No | No |
| 18482755 | PEPTIDE DEFICIENT-MHC CLASS I/CHAPERONE COMPOSITIONS AND METHODS | October 2023 | January 2026 | Allow | 27 | 2 | 0 | Yes | No |
| 18355946 | SINGLE CELL ANALYSIS OF TRANSPOSASE ACCESSIBLE CHROMATIN | July 2023 | April 2025 | Allow | 21 | 2 | 0 | No | No |
| 18329296 | MAMMALIAN CELL LINE FOR PROTEIN PRODUCTION AND LIBRARY GENERATION | June 2023 | November 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18324720 | METHOD FOR TRANSPOSASE MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | May 2023 | November 2025 | Abandon | 29 | 5 | 0 | No | No |
| 18252773 | CELL-FREE EXPRESSION OF ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND ANTIBODY DERIVATIVES | May 2023 | March 2026 | Allow | 34 | 0 | 0 | No | No |
| 18131577 | Deep Sequencing Profiling of Tumors | April 2023 | January 2026 | Allow | 33 | 4 | 0 | Yes | No |
| 18190288 | NANOPORE DEVICE AND METHODS OF BIOSYNTHESIS USING SAME | March 2023 | January 2024 | Allow | 10 | 0 | 0 | No | No |
| 18178367 | METHODS, COMPOSITIONS, AND SYSTEMS FOR CAPTURING PROBES AND/OR BARCODES | March 2023 | December 2024 | Allow | 22 | 4 | 0 | No | No |
| 18099913 | PROBE SET FOR ANALYZING A DNA SAMPLE AND METHOD FOR USING THE SAME | January 2023 | June 2025 | Allow | 29 | 3 | 0 | Yes | No |
| 18055297 | Fusion Proteins Comprising an Engineered Knottin Peptide and Uses Thereof | November 2022 | December 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 18050912 | FLEXIBLE SUBSTRATES FOR NUCLEIC ACID SYNTHESIS | October 2022 | February 2025 | Abandon | 28 | 3 | 0 | Yes | No |
| 17964771 | MICROFLUIDIC DEVICE FOR STORAGE AND WELL-DEFINED ARRANGEMENT OF DROPLETS | October 2022 | August 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17934829 | METHODS AND DEVICES FOR DETECTION OF PERIPHERAL MEMBRANE PROTEIN INTERACTIONS USING NONLINEAR OPTICAL TECHNIQUES | September 2022 | July 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17899860 | High-Throughput Screening Methods to Identify Small Molecule Targets | August 2022 | May 2024 | Allow | 21 | 1 | 0 | No | No |
| 17820409 | METHOD OF IDENTIFYING BIOMARKERS OF NEUROLOGICAL DISEASES AND DIAGNOSIS OF NEUROLOGICAL DISEASES | August 2022 | March 2026 | Abandon | 43 | 1 | 0 | No | No |
| 17816691 | METHODS AND SYSTEMS FOR MASK ALIGNMENT IN MANUFACTURING PROCESS OF ARRAYS | August 2022 | June 2025 | Abandon | 35 | 0 | 1 | No | No |
| 17815256 | COMPOSITIONS AND METHODS FOR TREATMENT | July 2022 | October 2025 | Allow | 39 | 0 | 1 | Yes | No |
| 17761383 | METHODS FOR DETERMINING THE SEVERITY AND PROGNOSIS OF RSV INFECTION | March 2022 | February 2026 | Abandon | 47 | 1 | 0 | No | No |
| 17690386 | METHOD FOR SYNTHESIZING DNA | March 2022 | November 2024 | Abandon | 32 | 1 | 1 | No | No |
| 17683059 | GENE SEQUENCING CHIP AND GENE SEQUENCING METHOD | February 2022 | April 2025 | Allow | 37 | 1 | 0 | No | No |
| 17680101 | PROTEINS TARGETING ORTHOLOGS | February 2022 | January 2026 | Allow | 47 | 3 | 0 | No | No |
| 17629398 | TEST STRIP AND METHOD FOR DETECTING AMYLOID BETA IN URINE | January 2022 | September 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17624295 | BIOMARKERS FOR IRRITABLE BOWEL SYNDROME | December 2021 | May 2025 | Allow | 40 | 0 | 0 | No | No |
| 17618811 | IMPROVEMENTS IN NUCLEIC ACID SEQUENCING | December 2021 | January 2026 | Allow | 49 | 1 | 0 | No | No |
| 17542196 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | December 2021 | January 2026 | Allow | 50 | 3 | 0 | Yes | No |
| 17528456 | ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF | November 2021 | October 2025 | Allow | 47 | 1 | 0 | No | No |
| 17453336 | METHODS AND COMPOSITIONS FOR DIAGNOSTICALLY-RESPONSIVE LIGAND-TARGETED DELIVERY OF THERAPEUTIC AGENTS | November 2021 | December 2025 | Abandon | 49 | 1 | 0 | No | No |
| 17608027 | BIOMARKER PANEL FOR SEPSIS ENCEPHALOPATHY | November 2021 | January 2026 | Allow | 51 | 1 | 1 | No | No |
| 17607801 | High-Throughput Screening Methods to Identify Small Molecule Targets | October 2021 | November 2025 | Abandon | 49 | 2 | 0 | No | No |
| 17607669 | METHOD FOR PERITONEAL METASTATIC CELL DETECTION AND ISOLATION THEREOF | October 2021 | January 2026 | Allow | 51 | 1 | 1 | Yes | No |
| 17447416 | MODULAR CHEMIRESISTIVE SENSOR FOR REAL-TIME ETHYLENE MONITORING | September 2021 | April 2025 | Allow | 43 | 0 | 0 | No | No |
| 17431193 | METHODS FOR DETERMINING KINETIC PARAMETERS OF A REACTION BETWEEN ANALYTE AND LIGANDS | August 2021 | June 2025 | Allow | 46 | 0 | 1 | Yes | No |
| 17392534 | MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER | August 2021 | October 2025 | Abandon | 50 | 0 | 1 | No | No |
| 17053792 | SOLID-PHASE SURFACE AND SOLUTION MOTION MODE AND MOTION DEVICE | July 2021 | July 2025 | Abandon | 56 | 1 | 1 | No | No |
| 17413148 | AMPLIFICATION METHODS AND SYSTEMS FOR MERFISH AND OTHER APPLICATIONS | June 2021 | July 2025 | Allow | 49 | 1 | 0 | Yes | No |
| 17296723 | SYSTEM AND METHOD FOR ANALYZING EXTRACELLULAR VESICLES WITH AN OPTICAL BIOSENSOR | May 2021 | January 2026 | Allow | 56 | 3 | 0 | Yes | No |
| 17181659 | DIGITAL LSPR FOR ENHANCED ASSAY SENSITIVITY | February 2021 | December 2025 | Abandon | 58 | 2 | 1 | Yes | No |
| 17175606 | METHODS AND DEVICES FOR DETECTION AND ACQUISITION OF BIOMARKERS | February 2021 | January 2025 | Abandon | 48 | 1 | 0 | No | No |
| 17267827 | DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES | February 2021 | July 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17172029 | METHODS AND COMPOSITIONS FOR SEQUENCING | February 2021 | November 2025 | Abandon | 58 | 4 | 0 | No | No |
| 17145197 | IMMUNOASSAY DETECTION DEVICE WITH TEST STRIP ACCOMMODATED IN A CAPILLARY TUBE | January 2021 | July 2025 | Abandon | 54 | 2 | 0 | No | No |
| 17258001 | METHODS AND COMPOSITIONS FOR ANALYZING PLATELETS BY MASS CYTOMETRY | January 2021 | November 2024 | Abandon | 46 | 1 | 0 | No | No |
| 17141682 | Methods, Systems and Compositions Thereof for Nucleic Acid Library Quality Control and Quantification | January 2021 | May 2025 | Abandon | 52 | 4 | 1 | No | No |
| 17055803 | Devices, Systems, and Methods of Electronic Modulation of Polymerase for DNA Synthesis | November 2020 | August 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17082940 | METHODS OF SINGLE-POLYPEPTIDE SEQUENCING AND RECONSTRUCTION | October 2020 | November 2024 | Abandon | 48 | 2 | 1 | No | No |
| 17079959 | COMPOSITIONS AND METHODS FOR THERAPEUTICS PRESCREENING | October 2020 | March 2025 | Allow | 53 | 5 | 0 | Yes | No |
| 17025011 | Methods, Compositions, and Systems for Classification of Genetic Variants of Unknown Significance | September 2020 | July 2025 | Abandon | 58 | 3 | 1 | No | No |
| 16969328 | KIT OR DEVICE AND METHOD FOR DETECTING DEMENTIA | August 2020 | September 2025 | Allow | 60 | 2 | 1 | Yes | No |
| 16968512 | ARRAY-BASED CYCLIC PEPTIDE LIBRARIES | August 2020 | November 2024 | Abandon | 52 | 6 | 0 | No | No |
| 16943067 | STABILIZED IMMUNOGLOBULIN DOMAINS | July 2020 | November 2024 | Allow | 52 | 1 | 1 | No | No |
| 16770693 | SCREENING METHOD FOR TELOMERASE REVERSE TRANSCRIPTASE (TERT) PHOSPHORYLATION INHIBITORS | June 2020 | November 2025 | Allow | 60 | 2 | 1 | No | No |
| 16548143 | IN VITRO DNA WRITING FOR INFORMATION STORAGE | August 2019 | November 2024 | Abandon | 60 | 4 | 1 | Yes | No |
| 16385735 | MOVABLE TYPE METHOD APPLIED TO PROTEIN-LIGAND BINDING | April 2019 | September 2024 | Allow | 60 | 1 | 0 | Yes | No |
| 16302345 | METHODS FOR IDENTIFICATION OF SAMPLES | November 2018 | January 2025 | Allow | 60 | 8 | 0 | Yes | No |
| 16074128 | NUCLEIC ACIDS ENCODING CHIMERIC POLYPEPTIDES FOR LIBRARY SCREENING | July 2018 | April 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 15485109 | Library Quantitation And Qualification | April 2017 | September 2025 | Allow | 60 | 11 | 1 | Yes | No |
| 15212215 | METHODS OF SELECTING ANTIBODIES AND ANTIBODY FRAGMENTS | July 2016 | May 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 15131101 | APPARATUS FOR ASSAY, SYNTHESIS AND STORAGE, AND METHODS OF MANUFACTURE, USE, AND MANIPULATION THEREOF | April 2016 | January 2018 | Allow | 21 | 2 | 0 | Yes | No |
| 14993792 | PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE | January 2016 | April 2018 | Allow | 27 | 0 | 1 | Yes | No |
| 14823571 | MANIPULATION OF MICROPARTICLES IN MICROFLUIDIC SYSTEMS | August 2015 | January 2017 | Allow | 18 | 1 | 0 | Yes | No |
| 14414916 | MULTI-SENSOR ARRAY COMPOUND AND METHODS OF USE THEREOF | January 2015 | January 2018 | Allow | 36 | 1 | 1 | Yes | No |
| 14073653 | PS-SPCL SEARCHING APPARATUS AND METHOD USING SURFACE PLASMON RESONANCE | November 2013 | April 2018 | Allow | 53 | 2 | 1 | No | No |
| 13761968 | TYROSINE KINASE BIOSENSORS AND METHODS OF USE | February 2013 | August 2016 | Allow | 43 | 3 | 1 | No | No |
| 13487605 | PROBE ARRAY BASE, METHOD FOR MANUFACTURING PROBE ARRAY BASE, METHOD FOR MANUFACTURING PROBE ARRAY | June 2012 | January 2014 | Allow | 19 | 2 | 1 | Yes | No |
| 13463212 | BETA-AMINO ACIDS | May 2012 | February 2014 | Allow | 21 | 1 | 1 | Yes | No |
| 13396352 | Methods and Compositions for the Target-localized Anchoring of Detectable Label | February 2012 | June 2016 | Allow | 52 | 4 | 1 | Yes | No |
| 13365554 | METHODS AND KITS USING EXTENDED RHODAMINE DYES | February 2012 | August 2013 | Allow | 19 | 2 | 2 | Yes | No |
| 13289542 | Ligand Libraries for Screening GPCRs | November 2011 | January 2013 | Abandon | 14 | 1 | 1 | No | No |
| 13207486 | IDENTIFYING ANTIGEN CLUSTERS FOR MONITORING A GLOBAL STATE OF AN IMMUNE SYSTEM | August 2011 | December 2013 | Allow | 28 | 1 | 1 | Yes | No |
| 12928312 | High throughput system for isolation, growth, and detection of lipid inclusions in bacteria | December 2010 | August 2015 | Allow | 56 | 2 | 1 | Yes | No |
| 12848888 | Stamping Apparatus For Biochips and Method For Operation Thereof | August 2010 | May 2015 | Allow | 58 | 2 | 1 | Yes | No |
| 12465719 | NOVEL DIARYLPHOSPHINE-CONTAINING COMPOUNDS, PROCESSES OF PREPARING SAME AND USES THEREOF AS TRIDENTATE LIGANDS | May 2009 | March 2013 | Allow | 46 | 2 | 1 | Yes | No |
| 12162799 | Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | August 2008 | July 2016 | Allow | 60 | 6 | 1 | No | No |
| 11884066 | Method and Array for the Replication and Analysis of Nucleic Acids | June 2008 | September 2015 | Allow | 60 | 4 | 2 | Yes | No |
| 12133190 | MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS | June 2008 | July 2016 | Allow | 60 | 3 | 1 | No | No |
| 11908223 | QUANTUM DOT TEMPLATE FOR FAST AND SIMULTANEOUS DETECTION OF DIFFERENT INFECTIOUS AGENTS | May 2008 | December 2013 | Allow | 60 | 3 | 2 | Yes | No |
| 11856099 | METHOD AND COMPOSITION FOR DETECTING PROTEIN-PROTEIN AND PROTEIN-NUCLEIC ACID INTERACTIONS | September 2007 | September 2013 | Allow | 60 | 2 | 1 | Yes | No |
| 10594182 | POLYMER PARTICLE | July 2007 | December 2010 | Allow | 51 | 1 | 1 | Yes | No |
| 11758735 | METHOD FOR DETECTING TARGET BIOLOGICAL MATERIAL USING DNA BARCODES | June 2007 | November 2010 | Allow | 41 | 1 | 1 | Yes | No |
| 11744112 | NUCLEIC ACID SAMPLE PURIFICATION AND ENRICHMENT WITH A THERMO-AFFINITY MICROFLUIDIC SUB-CIRCUIT | May 2007 | March 2011 | Allow | 46 | 2 | 2 | Yes | No |
| 11404807 | METHOD FOR SCREENING ANTI-ADHERENT COMPOUNDS ON POLYMERS FOR PREVENTING BIOFILM FORMATION | April 2006 | June 2009 | Allow | 38 | 3 | 1 | Yes | No |
| 10563463 | CUCURBITURIL DERIVATIVE-BONDED SOLID SUBSTRATE AND BIOCHIP USING THE SAME | January 2006 | July 2010 | Allow | 54 | 3 | 1 | No | No |
| 10540396 | PHOTOACTIVATABLE TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | September 2005 | February 2010 | Allow | 56 | 2 | 1 | Yes | No |
| 11231309 | PRINTING LIQUID SOLUTION ARRAYS FOR INORGANIC COMBINATORIAL LIBRARIES | September 2005 | January 2011 | Abandon | 60 | 6 | 3 | Yes | Yes |
| 11223825 | COMBINATORIAL ARTIFICIAL RECEPTORS INCLUDING PEPTIDE BUILDING BLOCKS | September 2005 | December 2010 | Allow | 60 | 0 | 2 | Yes | No |
| 11156653 | PNA CHIP USING PLASTIC SUBSTRATE COATED WITH EPOXY GROUP-CONTAINING POLYMER, METHOD OF MANUFACTURING THE PNA CHIP, AND METHOD OF DETECTING SINGLE NUCLEOTIDE POLYMORPHISM USING THE PNA CHIP | June 2005 | December 2009 | Allow | 54 | 2 | 1 | Yes | Yes |
| 11033416 | HETEROCYCLIC COMPOUNDS CONTAINING A NINE-MEMBERED CARBON-NITROGEN RING | January 2005 | March 2009 | Allow | 50 | 5 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GROSS, CHRISTOPHER M.
With a 75.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 42.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner GROSS, CHRISTOPHER M works in Art Unit 1684 and has examined 84 patent applications in our dataset. With an allowance rate of 77.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 54 months.
Examiner GROSS, CHRISTOPHER M's allowance rate of 77.4% places them in the 44% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by GROSS, CHRISTOPHER M receive 2.98 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by GROSS, CHRISTOPHER M is 54 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +43.1% benefit to allowance rate for applications examined by GROSS, CHRISTOPHER M. This interview benefit is in the 89% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 22.3% of applications are subsequently allowed. This success rate is in the 28% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 18.5% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 2% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 73.3% of appeals filed. This is in the 62% percentile among all examiners. Of these withdrawals, 45.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 84.2% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 29.8% of allowed cases (in the 99% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.